tailieunhanh - The neoepitope landscape of breast cancer: Implications for immunotherapy

Cancer immunotherapy with immune checkpoint blockade (CKB) is now standard of care for multiple cancers. The clinical response to CKB is associated with T cell immunity targeting cancer-induced mutations that generate novel HLA-binding epitopes (neoepitopes). | The neoepitope landscape of breast cancer Implications for immunotherapy

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN